Hermetica Superfood Encyclopedia
The Short Answer
Aniba rosaeodora essential oil is dominated by linalool (79–93.6% of total oil composition), a monoterpenol alcohol that exerts sedative, anticonvulsant, antidepressant, antioxidant, and antimicrobial activities primarily through modulation of GABAergic neurotransmission and free radical scavenging. Preclinical data demonstrate antioxidant EC₅₀ values of 15.46 µg/mL for the whole essential oil and 6.78 µg/mL for isolated linalool via ABTS radical scavenging, with antiparasitic activity against Trypanosoma cruzi epimastigotes at an IC₅₀ of 150.5 µg/mL, though no human clinical trials have yet confirmed these effects.
CategoryExtract
GroupAmazonian
Evidence LevelPreliminary
Primary Keywordrosewood essential oil benefits
Rosewood — botanical close-up
Health Benefits
**Anxiolytic and Sedative Effects**: The high linalool content (up to 93
6%) in rosewood essential oil is linked to modulation of GABA-A receptors, producing dose-dependent calming effects demonstrated in rodent models of anxiety and consistent with linalool's established psychopharmacological profile.
**Antioxidant Protection**
The essential oil exhibits concentration-dependent ABTS radical scavenging with an EC₅₀ of 15.46 µg/mL, while isolated linalool performs even more potently at 6.78 µg/mL, suggesting relevant protection against oxidative stress at the cellular level.
**Antifungal Activity**: When formulated in chitosan nanoemulsion, A
rosaeodora essential oil achieved complete inhibition of Aspergillus flavus growth at 0.8 µl/mL and fully suppressed aflatoxin B₁ biosynthesis at 0.6 µl/mL, indicating practical utility in food preservation and potentially topical antifungal applications.
**Antimicrobial Efficacy**
Isolated linalool from rosewood oil demonstrated measurable antibacterial activity with minimum inhibitory concentrations (MIC) of 550–650 µg/mL against tested bacterial strains, though these concentrations are relatively high and may limit clinical applicability without formulation enhancement.
**Antiparasitic Potential**: The essential oil showed IC₅₀ values of 150
5 ± 1.08 µg/mL against Trypanosoma cruzi epimastigotes and 911.6 ± 1.15 µg/mL against intracellular amastigotes in vitro, positioning it as a candidate for future investigation in Chagas disease research.
**Low Cytotoxicity Profile**
Both the whole essential oil and isolated linalool exhibited CC₅₀ values exceeding 1,000 µg/mL in peritoneal macrophage models, suggesting a favorable therapeutic index in preclinical cytotoxicity assays relative to their bioactive concentrations.
**Anticonvulsant and Antidepressant Activity**
Traditional and ethnopharmacological use, supported by linalool's documented preclinical activity in rodent seizure and forced-swim models, underpins claims of anticonvulsant and antidepressant potential, though human data specific to A. rosaeodora remain absent.
Origin & History
Natural habitat
Aniba rosaeodora is a medium-to-large canopy tree native to the tropical rainforests of the Amazon Basin, particularly concentrated in Brazil, Peru, Colombia, and French Guiana, where it thrives in humid lowland terra firme forests at elevations below 400 meters. The tree favors deep, well-drained lateritic soils with high annual rainfall exceeding 2,000 mm, and historically grew in dense natural stands along the Tapajós, Madeira, and Amazon river corridors. Overharvesting for its essential oil throughout the 20th century drove the species to near-threatened status, prompting Brazilian environmental regulations mandating sustainable agroforestry cultivation and restricting wild harvesting since the 1990s.
“Aniba rosaeodora, locally known in Brazil as 'pau-rosa' (pink wood), has been harvested by Amazonian indigenous communities for centuries, with the wood's fragrant heartwood used in ceremonial contexts and the essential oil applied topically as an insect repellent, wound treatment, and calming agent by groups including the Tikuna and Ribeirinho peoples of the upper Amazon. Commercial exploitation began in the early 20th century when the French perfumery industry identified rosewood oil as a primary source of natural linalool, making Brazil the world's leading supplier by the 1950s–1970s with peak annual production exceeding 400 tonnes of oil. The industrial demand for its linalool-rich oil—prized in formulating classic fragrances including Chanel No. 5—led to the destruction of enormous tracts of wild rosewood forest, fundamentally altering its ecological and cultural availability and prompting IBAMA (Brazil's environmental agency) to regulate harvesting and promote agroforestry replanting programs beginning in 1992. Today, sustainable leaf-distillation methods are being developed as an alternative to whole-tree felling, preserving both the species and the traditional knowledge surrounding its therapeutic applications.”Traditional Medicine
Scientific Research
The evidence base for Aniba rosaeodora consists exclusively of in vitro laboratory assays and preclinical animal studies; no peer-reviewed human clinical trials have been published as of the current literature review, representing a significant evidentiary gap. Available in vitro studies have quantified antioxidant activity via ABTS radical scavenging (EC₅₀ 15.46 µg/mL for the essential oil; 6.78 µg/mL for linalool), antimicrobial MIC values (550–650 µg/mL for linalool), and antiparasitic IC₅₀ values against Trypanosoma cruzi (150.5 µg/mL epimastigote form), providing a mechanistic framework but not demonstrating clinical efficacy. Nanoemulsion encapsulation studies using chitosan matrices have advanced the applied formulation science, demonstrating complete Aspergillus flavus inhibition at 0.8 µl/mL, yet these remain proof-of-concept investigations without progression to clinical testing. The broader pharmacological claims related to sedation, anticonvulsant action, and antidepressant effects are largely inferred from the extensive human and animal literature on isolated linalool rather than from studies specifically conducted with A. rosaeodora preparations, limiting direct extrapolation.
Preparation & Dosage
Traditional preparation
**Steam-Distilled Essential Oil (aromatherapy)**
2–4 drops diffused in an ultrasonic diffuser for 30–60 minutes; inhalation is the most documented delivery route for linalool's CNS effects in preclinical and limited human linalool studies.
**Topical Application (diluted essential oil)**
Dilute to 1–3% in a carrier oil (e.g., fractionated coconut or jojoba oil) for dermal application; higher concentrations are not recommended without professional guidance due to potential sensitization.
**Chitosan Nanoemulsion (experimental/food preservation)**
Effective concentrations of 0.6–0.8 µl/mL demonstrated complete antifungal activity in vitro; no standardized oral supplement formulation currently exists for human use.
**Standardization**
Quality rosewood essential oil should be standardized to a minimum of 79% linalool content by gas chromatography-mass spectrometry (GC-MS) analysis to ensure batch consistency.
**Traditional Preparation**
5–10 g of dried wood chips in 250 mL water for 15 minutes and consumed as a calming tea, though this practice is now restricted due to conservation status
In Amazonian ethnomedicine, bark and wood decoctions were historically prepared by simmering .
**Timing**
Aromatherapy applications are typically used 30–60 minutes before sleep for sedative intent; no pharmacokinetic timing data from clinical trials exist for oral preparations.
**Important Note**
No standardized oral supplement dose has been established in human clinical trials; all dosing references are extrapolated from in vitro experimental concentrations or linalool-specific research.
Nutritional Profile
Aniba rosaeodora is used exclusively as an essential oil extract rather than as a whole food, and therefore does not contribute meaningful macronutrients, vitamins, or minerals to the diet. The essential oil's phytochemical composition is well-characterized: linalool (79.0–93.6%) as the dominant monoterpenol, with minor constituents including α-terpinolene (3.37%), linalool cis-oxide (3.03%), β-selinene (~2.0%), aromadendrene oxide (~2.5%), and (E)-nerolidyl acetate (~1.5%) in typical chemotypes, while variant chemotypes contain benzyl benzoate (29.3–44.1%) and δ-cadinene (4.8–12.0%). Linalool is highly lipophilic (log P ≈ 2.97) and exhibits good transdermal and inhalational absorption, with rapid pulmonary uptake upon aromatherapy administration and plasma detection within minutes in animal models. The oil is soluble in 70% ethanol at a 1:2 ratio, facilitating alcohol-based cosmetic and tincture formulations, and bioavailability is enhanced through nanoemulsion encapsulation strategies that improve aqueous dispersibility.
How It Works
Mechanism of Action
Linalool, comprising 79–93.6% of Aniba rosaeodora essential oil, is the primary pharmacologically active constituent and acts as a positive allosteric modulator of GABA-A receptors, increasing chloride ion influx and producing neuroinhibitory effects that underlie its sedative, anxiolytic, and anticonvulsant properties in preclinical models. Linalool also inhibits voltage-gated sodium and calcium channels in neuronal membranes, attenuating excitatory neurotransmission and contributing to its anticonvulsant and analgesic profiles observed in animal studies. Its antioxidant mechanism involves direct free radical scavenging of reactive oxygen species (ROS) through hydrogen atom transfer, as quantified by ABTS assay (EC₅₀ 6.78 µg/mL for pure linalool), and may additionally involve upregulation of endogenous antioxidant enzymes such as superoxide dismutase and catalase, as suggested by related monoterpenol research. The antimicrobial and antifungal activities are attributed to linalool's lipophilicity enabling disruption of microbial cell membrane integrity, dissipation of the proton motive force, and inhibition of ergosterol biosynthesis in fungal species, while the minor constituent benzyl benzoate (present at 29.3–44.1% in some chemotypes) may contribute additional antiparasitic membrane-disrupting activity.
Clinical Evidence
No clinical trials have been conducted specifically using Aniba rosaeodora preparations in human participants, making it impossible to report clinical effect sizes, confidence intervals, or validated therapeutic outcomes for this ingredient as a discrete entity. The sedative, anticonvulsant, and antidepressant properties attributed to rosewood essential oil are primarily supported by translation from the linalool-specific clinical and preclinical literature, where small randomized trials (typically n=20–60) have demonstrated acute anxiolytic effects of inhaled linalool in healthy volunteers, but these trials did not use A. rosaeodora oil directly. Cytotoxicity data from macrophage cell models (CC₅₀ >1,000 µg/mL) provide preliminary reassurance regarding safety at concentrations above those required for antioxidant and antiparasitic activity, but are insufficient for establishing human safety thresholds. Overall confidence in clinical efficacy claims for rosewood specifically remains very low, and the ingredient should be regarded as in the exploratory preclinical phase pending human investigation.
Safety & Interactions
Aniba rosaeodora essential oil demonstrates low acute cytotoxicity in vitro, with CC₅₀ values exceeding 1,000 µg/mL in peritoneal macrophage models for both the whole oil and isolated linalool, suggesting a favorable safety margin at bioactive concentrations; however, no formal human toxicological studies or adverse event reporting exists for this specific botanical. Topical application of undiluted essential oil may cause dermal irritation or allergic contact sensitization, consistent with general essential oil safety guidelines, and the oil should always be diluted to 1–3% for skin use; individuals with known terpene or fragrance allergies should exercise caution. Linalool's GABA-A modulatory activity raises a theoretical risk of additive CNS depression when combined with benzodiazepines, barbiturates, alcohol, opioids, or other sedative medications, though no pharmacokinetic drug interaction studies exist for A. rosaeodora preparations specifically. Use during pregnancy and lactation is not recommended due to the absence of safety data and the potential for uterotonic effects associated with high-dose terpenoid exposure; the species' conservation-restricted status also limits availability of standardized preparations for any therapeutic context.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Aniba rosaeodora DuckePau-rosaBrazilian rosewoodBois de roseCayenne rosewood
Frequently Asked Questions
What is rosewood essential oil good for?
Rosewood essential oil from Aniba rosaeodora is used primarily for its sedative, anxiolytic, and antioxidant properties, attributed to its high linalool content (79–93.6% of the oil). Preclinical studies demonstrate antioxidant EC₅₀ values of 15.46 µg/mL and antiparasitic activity against Trypanosoma cruzi, but human clinical trials confirming these benefits have not yet been conducted. It is also employed in aromatherapy for stress relief and in topical formulations for its antimicrobial properties.
What percentage of linalool is in Aniba rosaeodora essential oil?
Linalool comprises 79.0–93.6% of Aniba rosaeodora essential oil across different populations and extraction batches, making it one of the richest natural plant sources of this monoterpenol. Minor constituents include α-terpinolene (3.37%), linalool cis-oxide (3.03%), and β-selinene (~2.0%), though some chemotypes show significant variation with benzyl benzoate (29.3–44.1%) as an alternative major compound. Quality commercial oils should be verified by GC-MS analysis to confirm standardized linalool content.
Is Aniba rosaeodora (rosewood) essential oil safe to use?
In vitro cytotoxicity studies show CC₅₀ values exceeding 1,000 µg/mL in macrophage models, indicating low acute cytotoxicity at concentrations well above those needed for antioxidant and antimicrobial activity. However, no formal human safety studies exist, and undiluted topical application can cause skin irritation or sensitization; essential oil should be diluted to 1–3% in a carrier oil. Use during pregnancy or alongside sedative medications (benzodiazepines, alcohol) is not recommended due to GABA-A modulatory activity and lack of safety data.
How does rosewood oil compare to other linalool-containing essential oils like lavender?
Aniba rosaeodora essential oil contains a substantially higher proportion of linalool (79–93.6%) compared to lavender (Lavandula angustifolia), which typically contains 25–45% linalool alongside significant linalool acetate and other terpenes. This makes rosewood oil a more concentrated source of linalool per unit volume, potentially offering more pronounced linalool-mediated effects at equivalent doses. However, lavender has a considerably larger body of human clinical evidence supporting its anxiolytic efficacy, whereas rosewood-specific human data is entirely absent.
Why is Aniba rosaeodora endangered and how does this affect its availability?
Aniba rosaeodora was intensively harvested throughout the 20th century primarily for the French perfumery industry, which required whole-tree felling to steam-distill the linalool-rich heartwood oil, with Brazil producing over 400 tonnes of oil annually at peak output. This led to severe depletion of wild populations and prompted Brazilian environmental agency IBAMA to impose strict harvesting regulations in 1992, classifying the species as vulnerable. Today, sustainable leaf-distillation from cultivated trees is being promoted as an alternative, but conservation restrictions limit commercial availability and increase the cost and variability of authentic rosewood essential oil.
What is the difference between rosewood essential oil and rosewood extract in supplements?
Rosewood essential oil is a volatile, steam-distilled product containing the aromatic compounds like linalool, while rosewood extract may refer to concentrated or standardized preparations of the plant's bioactive constituents. Essential oil is typically used in aromatherapy or topical applications due to its volatile nature, whereas extracts may be formulated into capsules or tinctures for internal supplementation. The extraction method significantly affects the concentration and bioavailability of specific compounds, with standardized extracts often providing more consistent linalool levels than pure essential oils.
Does rosewood essential oil interact with sedative medications or benzodiazepines?
Because rosewood oil's linalool acts on GABA-A receptors similarly to benzodiazepines, concurrent use with prescription sedatives or anti-anxiety medications may potentiate effects and increase drowsiness or central nervous system depression. Individuals taking medications like diazepam, lorazepam, or other CNS depressants should consult a healthcare provider before supplementing with rosewood, as additive effects could occur. This interaction is particularly relevant for those using rosewood for its anxiolytic properties, as combining mechanisms of action may exceed safe dosing thresholds.
What does research show about rosewood's antioxidant effectiveness compared to other essential oils?
Rosewood essential oil demonstrates concentration-dependent ABTS radical scavenging activity, indicating antioxidant potential, though direct comparative clinical trials against other essential oils remain limited. Most evidence for its antioxidant benefits comes from in vitro studies, which show promise but may not fully translate to human bioavailability and systemic effects. Stronger clinical evidence exists for rosewood's anxiolytic effects via linalool than for its antioxidant capacity in living organisms.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w rosewood-aniba-rosaeodora curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
